article thumbnail

The current pricing of cancer treatments is unsustainable

World of DTC Marketing

From 2009 to 2019, the median monthly treatment costs for new drugs at launch reached $11,755 in the U.S… From 2009-10 to 2018-19, the lowest average monthly costs for new cancer drugs approved by the U.S. One-quarter of all cancer patients chose not to fill a prescription due to cost, according to a 2013 study in The Oncologist.

article thumbnail

Drug side effects should be easier to understand

World of DTC Marketing

SUMMARY: Per the Times, “what if consumers could calculate the benefits and risks of taking a prescription drug as easily as they can gauge the carbohydrates and calories in an Oreo cookie?” There is no doubt that drug side effects are key reasons patients don’t fill prescriptions, and the FDA has not made it easy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The current pharma business model is unsustainable

World of DTC Marketing

In pharma, growth depends on new products with hefty price tags when over 80% of voters want lower costs for their prescription drugs. While that sounds encouraging, most cancer drugs launched between 2009 and 2014 cost more than USD 100,000 annually. Biogen’s failure should be a warning to other pharma companies.

Pharma 210
article thumbnail

Common sense approach to the pharma industry

World of DTC Marketing

Pharma companies are still too focused on profits while people continue to rely on prescription drugs to compensate for unhealthy lifestyles. While pharma continues to advertise help for prescription drug prices, 25% of people say they can’t afford their medications. Are prescription drugs priced too high?

Pharma 155
article thumbnail

What the latest DEA Proposed Rule Means for Telemedicine Prescribing of Controlled Substances

Nixon Gwilt Law

Notably, this rulemaking does not propose to implement the “special registration” for telemedicine providers the DEA has been promising since the Ryan Haight Act passed in 2009. Instead, it would create a new regulatory category of the “practice of telemedicine.” We will publish a second post shortly on that proposed rule and link it here.

article thumbnail

Bridging the healthcare digital divide: a gradual approach to adopting ePI

European Pharmaceutical Review

It emphasises its ability to make information interoperable with electronic health systems such as e-prescription and electronic health records. Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC.”

article thumbnail

Effective Pharma Ad Types & Stats

Pharma Marketing Network

“Direct-to-Consumer Advertising of Prescription Drugs.” “The Impact of Direct-to-Consumer Advertising on Prescription Drug Spending.” ” Pharmacy and Therapeutics, 2009. . ” Pharmacy and Therapeutics, 2009. . “Pharmaceutical Advertising Spending in the US.” ” U.S.

Pharma 52